Profile of Cerebrospinal Fluid and Serum Cytokines in Patients with Relapsing-Remitting Multiple Sclerosis. A Correlation with Clinical Activity
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 20 (3) , 373-382
- https://doi.org/10.3109/08923979809034820
Abstract
Levels of tumor necrosis factor (TNF)-α, granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin (IL)-10 and transforming growth factor (TGF)-β in cerebrospinal fluid (CSF) and serum of 29 patients with multiple sclerosis (MS) of the relapsing-remitting type and of 20 controls with other non inflammatory neurological diseases were studied. Sixteen patients were in the active phase of disease and 13 in remission. In CSF, higher IL-10 and TGF-β concentrations were found in patients with a stable phase of MS, while in the active phase there were elevated levels of TNF-α and GM-CSF. These results suggest that a different cytokine pattern could be probably involved in the pathogenesis of relapsing-remitting MS.Keywords
This publication has 23 references indexed in Scilit:
- The adhesion molecule and cytokine profile of multiple sclerosis lesionsAnnals of Neurology, 1995
- Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remissionZeitschrift für Neurologie, 1995
- Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosisNeurology, 1994
- Markers of Activated T Lymphocytes and T Cell Receptor Gamma/ Delta+ in Patients with Multiple SclerosisEuropean Neurology, 1993
- In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosisJournal of Neuroimmunology, 1992
- Serum and CSF levels of IL‐2, sIL‐2R, TNF‐α, and IL‐1β in chronic progressive multiple sclerosisNeurology, 1991
- Soluble interleukin‐2 receptors in cerebrospinal fluid from individuals with various neurological disordersAnnals of Neurology, 1990
- Tumor necrosis factor identified in multiple sclerosis brain.The Journal of Experimental Medicine, 1989
- Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumoursJournal of Neuroimmunology, 1989
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989